PENELOPE (Completed)
Prevalence of unmet target LDL-C recommendations in very high risk patients despite high intensity lipid modifying therapy
- Medicine
- Niet van toepassing
- Population
- ASCVD
- Phase
- IV
- Starting year
- 2018
Publications by WCN study
- ACTION ASCVD
- AEGIS ASCVD
- AFFIRM-AHF Heart failure
- APPRAISE-2 ASCVD
- ARISTOTLE Arrhythmia
- ARTESiA Arrhythmia
- ARTS-HF Heart failure
- ASSERT-2 Arrhythmia
- ATLAS-2 ASCVD
- AUGUSTUS ASCVD
- BIOMARCS ASCVD
- C-SCADE8 Diabetes mellitus
- CAMELLIA Diabetes mellitus
- CANTOS ASCVD
- CAPACITY-COVID Registry Primairy prevention cardiovasular disease
- CLEAR 1002-043 ASCVD
- CLEAR Harmony 1002-040 Primairy prevention cardiovasular disease
- CLEAR SYNERGY (OASIS 9) ASCVD
- COMPASS ASCVD
- COMPASS-LTOLE ASCVD
- CORONA Heart failure
- dal-GenE ASCVD
- Dal-OUTCOMES ASCVD
- DAPA-HFrEF Heart failure
- DECISION Heart failure
- DELIVER Heart failure
- DIAMOND Heart failure
- ELIXA Diabetes mellitus
- EMPEROR_HFrEF Heart failure
- Emphasis Heart failure
- FEMINA ASCVD
- GALACTIC HF Heart failure
- GEMINI ASCVD
- HARMONY Diabetes mellitus
- Improve-IT ASCVD
- LATITUDE - deel A ASCVD
- LoDoCo2 ASCVD
- NOAH - AFNET 6 Arrhythmia
- NODE-301 part 2 (RAPID) Arrhythmia
- ODYSSEY ASCVD
- Origin (Lantus) Diabetes mellitus
- ORIGINALE Diabetes mellitus
- PADIT Arrhythmia
- PARADIGM-2314 Heart failure
- PARAGON Heart failure
- PEGASUS TIMI54 ASCVD
- PENELOPE ASCVD
- PIONEER Arrhythmia
- PLATO ASCVD
- PREVALENCE Heart failure
- PROMINENT Diabetes mellitus
- RACE Arrhythmia
- RACE II Arrhythmia
- RACE III Arrhythmia
- RE-LY Arrhythmia
- REDUCE-it ASCVD
- RELAX-AHF-II Heart failure
- RELY-able Arrhythmia
- ROCKET-AF Arrhythmia
- RUBY I ASCVD
- SELECT ASCVD
- SHIFT Heart failure
- SIGNIFY ASCVD
- SOLID TIMI52 ASCVD
- SOLOIST-WHF Heart failure
- SPIRE-1 ASCVD
- SPIRE-2 ASCVD
- Stability LPL II ASCVD
- STRENGTH ASCVD
- TECOS ASCVD
- THEMIS Diabetes mellitus
- TIDE Diabetes mellitus
- TIMI 50, TRA-2P ASCVD
- TRA-CER ASCVD
- Trilogy ASCVD
- TRUE AHF Heart failure
- Warcef Heart failure